BioMarin Pharmaceutical Inc.

Q3 2022 13F Holders

Symbol
BMRN
CUSIP
09061G101
Type
Equity
Class
COM
Num filers
559
Total reported value, excl. options
$15.5B
Manager Report Date Value ($000) Shares Option Type